Publications 2024

Thunold S, Hernes E, Farooqi S, Öjlert ÅK, Francis RJ, Nowak AK, Szejniuk WM, Nielsen SS, Cedres S, Perdigo MS, Sørensen JB, Meltzer C, Mikalsen LTG, Helland Å, Malinen E, Haakensen VD (2024)
Outcome prediction based on [18F]FDG PET/CT in patients with pleural mesothelioma treated with ipilimumab and nivolumab +/- UV1 telomerase vaccine
Eur J Nucl Med Mol Imaging (in press)
DOI 10.1007/s00259-024-06853-0, PubMed 39133306

Aaløkken TM, Ashraf H, Einvik G, Lerum TV, Meltzer C, Rodriguez JR, Skjønsberg OH, Stavem K (2024)
CT abnormalities 3 and 12 months after hospitalization for COVID-19 and association with disease severity: A prospective cohort study
PLoS One, 19 (5), e0302896
DOI 10.1371/journal.pone.0302896, PubMed 38709747

Publications 2023

Lerum TV, Meltzer C, Rodriguez JR, Aaløkken TM, Brønstad E, Aarli BB, Aarberg-Lund KM, Durheim MT, Ashraf H, Einvik G, Skjønsberg OH, Stavem K (2023)
A prospective study of pulmonary outcomes and chest computed tomography in the first year after COVID-19
ERJ Open Res, 9 (2)
DOI 10.1183/23120541.00575-2022, PubMed 36915802

Publications 2021

Lerum TV, Maltzahn NN, Aukrust P, Trøseid M, Henriksen KN, Kåsine T, Dyrhol-Riise AM, Stiksrud B, Haugli M, Blomberg B, Kittang BR, Johannessen A, Hannula R, Aballi S, Kildal AB, Eiken R, Dahl TB, Lund-Johansen F, Müller F, Rodriguez JR, Meltzer C, Einvik G, Ueland T, Olsen IC, NOR-SOLIDARITY Consortium et al. (2021)
Persistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9
Sci Rep, 11 (1), 23205
DOI 10.1038/s41598-021-02547-x, PubMed 34853380

Lerum TV, Aaløkken TM, Brønstad E, Aarli B, Ikdahl E, Lund KMA, Durheim MT, Rodriguez JR, Meltzer C, Tonby K, Stavem K, Skjønsberg OH, Ashraf H, Einvik G (2021)
Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19
Eur Respir J, 57 (4)
DOI 10.1183/13993003.03448-2020, PubMed 33303540

Rossi Norrlund R, Meltzer C, Söderman C, Johnsson ÅA, Vikgren J, Molnar D, Gilljam M, Båth M (2021)
EVALUATION OF TWO CHEST TOMOSYNTHESIS CYSTIC FIBROSIS SCORING SYSTEMS USING HIGH-RESOLUTION COMPUTED TOMOGRAPHY BRODY SCORING AS REFERENCE
Radiat Prot Dosimetry, 195 (3-4), 443-453
DOI 10.1093/rpd/ncab057, PubMed 33948650

Publications 2020

Meltzer C, Fagman E, Vikgren J, Molnar D, Borna E, Beni MM, Brandberg J, Bergman B, Båth M, Johnsson ÅA (2020)
Surveillance of small, solid pulmonary nodules at digital chest tomosynthesis: data from a cohort of the pilot Swedish CArdioPulmonary bioImage Study (SCAPIS)
Acta Radiol, 62 (3), 348-359
DOI 10.1177/0284185120923106, PubMed 32438877

Mirzai M, Meltzer C, Vikgren J, Norrlund RR, Gottfridsson B, Johnsson Å, Båth M, Svalkvist A (2020)
The Effect of Dose Reduction on Overall Image Quality in Clinical Chest Tomosynthesis
Acad Radiol, 28 (10), e289-e296
DOI 10.1016/j.acra.2020.05.041, PubMed 32709583

Publications 2018

Meltzer C, Vikgren J, Bergman B, Molnar D, Norrlund RR, Hassoun A, Gottfridsson B, Båth M, Johnsson ÅA (2018)
Detection and Characterization of Solid Pulmonary Nodules at Digital Chest Tomosynthesis: Data from a Cohort of the Pilot Swedish Cardiopulmonary Bioimage Study
Radiology, 287 (3), 1018-1027
DOI 10.1148/radiol.2018171481, PubMed 29613826

Publications 2016

Meltzer C, Båth M, Kheddache S, Ásgeirsdóttir H, Gilljam M, Johnsson ÅA (2016)
VISIBILITY OF STRUCTURES OF RELEVANCE FOR PATIENTS WITH CYSTIC FIBROSIS IN CHEST TOMOSYNTHESIS: INFLUENCE OF ANATOMICAL LOCATION AND OBSERVER EXPERIENCE
Radiat Prot Dosimetry, 169 (1-4), 177-87
DOI 10.1093/rpd/ncv556, PubMed 26842827